On Oct. 26, GlaxoSmithKline (NYSE:GSK) released third-quarter earnings for the period ended Sept. 30.

  • Strong pharmaceutical sales in the U.S. led to 8.7% revenue growth.
  • Decline in selling, general, and administration expenses led to 24.5% increase in net profit.
  • Tax and increase in working capital led to decline in cash generated from operations, thereby lowering FCF.

(Figures in millions except per-share data)

Income Statement Highlights

Avg. Est.

Q3 2006

Q3 2005

Change

Sales

N/A

$10,617

$9,763

8.7%

Net Profit

--

$2,681

$2,154

24.5%

EPS

N/A

$0.47

$0.38

23.7%

Diluted Shares

--

5,711

5,712

(0%)



Get back to basics with a look at the income statement.

Margin Checkup

Q3 2006

Q3 2005

Change*

Gross Margin

78.34%

78.36%

(0.02)

Operating Margin

35.86%

32.59%

3.27

Net Margin

25.27%

22.90%

2.37

*Expressed in percentage points.

Margins are the earnings engine. See how they work.

Balance Sheet Highlights

Assets

Q3 2006

Q3 2005

Change

Cash + ST Invest.

$6,333

$11,374

(44.3%)

Accounts Rec.

$9,821

$8,587

14.4%

Inventory

$4,662

$3,892

19.8%



Liabilities

Q3 2006

2005

Change

Accounts Payable

$8,623

$8,101

6.4%

Long-Term Debt

$9,073

$9,221

(1.6%)



Learn the ways of the balance sheet.

Cash Flow Highlights

Q3 2006

Q3 2005

Change

Cash From Ops.

($116)

$3,239

N/A

Capital Expenditures

$690

$423

63.1%

Free Cash Flow

($806)

$2,816

N/A



Find out why Fools always follow the money.

Related Companies:

  • Novartis (NYSE:NVS)
  • Pfizer (NYSE:PFE)
  • Sanofi-Aventis (NYSE:SNY)

Related Foolishness:

GlaxoSmithKline is a Motley Fool Income Investor pick, while Pfizer is a Motley Fool Inside Value selection.

Fool by Numbers is designed to give you the raw earnings information in a timely fashion, putting all the numbers you need in one easy-to-read place. But at The Motley Fool, we believe numbers tell only part of the story, so check Fool.com for more of our in-depth discussion of what the numbers mean. This data has been provided by Netscribes. To provide feedback on this article, please click on the "feedback" button below.